[Adult acute lymphoblastic leukemia - 20-year treatment results at TYKS].
Approximately 30 cases of adult acute lymphoblastic leukemia (ALL) emerge in Finland yearly. In literature 35 to 40% of those under the age of 60 are reported to recover from their illness. Of the 67 adult ALL patients treated at the Turku University Hospital from 1990 to 2010, 96% achieved remission. The five-year survival rate was 53%. After remission, an allogeneic stem cell transplant was performed for 22 patients (37%), with 38 patients (63%) continuing on cytotoxic drugs. There was no difference in survival between modes of treatment or risk groups.
Rami
R
Nylund
Maija
M
Itälä-Remes
Tommi
T
Kauko
Marjut
M
Kauppila
Mervi
M
Putkonen
Urpu
U
Salmenniemi
Tommi
T
Salmi
Kari
K
Remes
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000453:epidemiology / Q000628:therapy*; D011379:Prognosis; D012074:Remission Induction; D033581:Stem Cell Transplantation; D015996:Survival Rate; D016896:Treatment Outcome
D000970:Antineoplastic Agents